Mkts

PDS Biotechnology Corporation

NASDAQ: PDSB
$0.99-0.09 (-7.87%)
As of Nov 10, 3:50 PM ET

Key statistics

Day range
0.941.05
52-week range
0.201.79
Today
Open1.03
Previous close0.99
Volume—
Valuation
Market cap113.93M
P/E ratio—
EPS (TTM)-0.65
Income & risk
Dividend / yield—
Beta1.25
Avg volume18.51M
Discussion

PDSB News

Stories mentioning PDSB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development3,4574,5764,2135,8316,8044,528
Sales General & Admin
Total Operating Expenses6,5218,1407,6239,10610,1798,684
Operating Income (Loss)(6,521)(8,140)(7,623)(9,106)(10,179)(8,684)
Interest Income187.00281.00334.00378.00667.00675.00
Interest Expense
Other Expense
Pretax Income(7,349)(9,009)(9,434)(9,659)(10,727)(9,197)
Tax Provision0.000.000.00(1,170)0.00(869.00)
Net Income (Loss)(7,349)(7,563)(9,009)(9,434)(8,489)(7,952)(10,727)(8,328)
Earnings Per Share (Basic)(0.13)(0.16)(0.19)(0.21)(0.21)(0.22)(0.29)(0.23)
Earnings Per Share (Diluted)(0.13)(0.16)(0.19)(0.21)(0.21)(0.22)(0.29)(0.23)
Weighted Average Shares Outstanding (Basic)55,49646,38446,87045,90340,52136,45336,80736,694
Weighted Average Shares Outstanding (Diluted)55,49646,38446,87045,90340,52136,45336,80736,694

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PDSB

PDS Biotechnology Corporation (NASDAQ: PDSB) is a stock listed on the Nasdaq Stock Market under the ticker symbol PDSB. It last traded at $0.9900 (Nov 10, 2026, 3:50 PM ET), down 7.9% on the day. That gives PDS Biotechnology a market capitalisation of $113.9M.

Over the past 52 weeks PDSB has traded between $0.2000 and $1.79.

For the quarter ended Mar 31, 2026 it reported a net loss of $7.3M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$7.3M
Dec 31, 2025—-$7.6M
Sep 30, 2025—-$9.0M
Jun 30, 2025—-$9.4M

From PDS Biotechnology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…